Ernesto Bertarelli
Founder bij B Flexion Capital Holdings Jersey Ltd.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Todd Tuckner | M | 59 | 20 jaar | |
| Stefan Mario Meister | M | 58 |
B Flexion Capital Holdings Jersey Ltd.
 B Flexion Capital Holdings Jersey Ltd. Investment ManagersFinance B Flexion Capital Holdings Jersey Ltd. is a British pharmaceutical portfolio company of b-flexion, a private investment firm founded in 1906 by Ernesto Bertarelli. The firm partners with sophisticated capital to deliver exceptional value over generations and contributes positively to society. B-flexion acquires and builds asset management investment partnerships in various fields, including private equity, venture capital, infrastructure, technology, real estate, hedge funds, public and private credit, and public securities. The company is chaired by Ernesto Bertarelli and has offices across the world.
Waypoint Capital Holdings (Jersey) Ltd.
 Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | 3 jaar |
| Cyrus Jilla | M | - |
B Flexion Capital Holdings Jersey Ltd.
B Flexion Capital Holdings Jersey Ltd. Investment ManagersFinance B Flexion Capital Holdings Jersey Ltd. is a British pharmaceutical portfolio company of b-flexion, a private investment firm founded in 1906 by Ernesto Bertarelli. The firm partners with sophisticated capital to deliver exceptional value over generations and contributes positively to society. B-flexion acquires and builds asset management investment partnerships in various fields, including private equity, venture capital, infrastructure, technology, real estate, hedge funds, public and private credit, and public securities. The company is chaired by Ernesto Bertarelli and has offices across the world.
Waypoint Capital Holdings (Jersey) Ltd.
Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | 4 jaar |
| Georges Muller | M | 84 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland.
Bertarelli & Cie
| 16 jaar |
| Markus U. Diethelm | M | 66 | 16 jaar | |
| Josef Stadler | M | 61 | 15 jaar | |
| Rodolfo Bogni | M | 77 |
Waypoint Capital Holdings (Jersey) Ltd.
Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | - |
| Elias Zerhouni | M | 72 |
Waypoint Capital Holdings (Jersey) Ltd.
Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | 4 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| François Naef | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 19 jaar |
| Helmut Gunter Wilhelm Panke | M | 77 | 11 jaar | |
| Thomas Naratil | M | 62 | 20 jaar | |
| Robert Mills | M | 74 | 10 jaar | |
| Bruno Gehrig | M | 77 | 4 jaar | |
| Sally T. Bott | F | 74 | 3 jaar | |
| Rainer-Marc Frey | M | 61 | 6 jaar | |
| Peter Anton Joseph Kurer | M | 74 | 8 jaar | |
| Kaspar Villiger | M | 83 | 3 jaar | |
| Michel Demaré | M | 67 | - | |
| Roland Baumann | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 16 jaar |
| Peter Voser | M | 64 | 5 jaar | |
| Paul H. Arni | M | 60 | 15 jaar | |
| John Jenkins | M | 66 | 12 jaar | |
| Yong Hao Pu | M | 66 | 11 jaar | |
| Kathryn L. Biberstein | F | 65 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 7 jaar |
| Patrick Bont | M | 49 | 4 jaar | |
| Karin Schmidt | F | 51 | 16 jaar | |
| Reto Erdin | M | 54 | 3 jaar | |
| Thomas Michael Pixner | M | - | 5 jaar | |
| Peter Ding | M | 57 | 6 jaar | |
| André Fernandes Lopes Dias | M | - | 3 jaar | |
| Tat Pun Ng | M | 79 | 5 jaar | |
| Stephan Kirschbaum | M | 57 | 4 jaar | |
| Lay Khiam Ong | M | 76 | 5 jaar | |
| Gerhard Wilhelm Fusenig | M | 60 | 9 jaar | |
| Beat Oberlin | M | 69 | 10 jaar | |
| Jürg Zeltner | M | 56 | - | |
| Jean-Pierre Gotteland | M | 59 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 9 jaar |
| Ulrich Körner | M | 61 | 10 jaar | |
| William Greenberg | M | 56 | 4 jaar | |
| Allan Shaw | M | 59 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 2 jaar |
| Richard O. Ebner | M | - | 2 jaar | |
| Richard Samuelson | M | - | 14 jaar | |
| Matthew Engler | M | - | 4 jaar | |
| John Katzenmeyer | M | - | 6 jaar | |
| Ari Rubin | M | - | 3 jaar | |
| Frederico de Chaves | M | 40 | 13 jaar | |
| Adam Deutsch | M | 37 | 1 jaar | |
| Simon Wespi | M | - | 12 jaar | |
| Lukas Hoppe | M | - | 7 jaar | |
| Christoph Kanneberger | M | - | 3 jaar | |
| Man Yu Cheung | M | 50 | 3 jaar | |
| Nimesh Patel | M | 47 | 7 jaar | |
| Roland Leuenberger | M | 56 | 2 jaar | |
| David Schmid | M | 42 | 2 jaar | |
| Riccardo Boscardin | M | 72 | 12 jaar | |
| Hong Ping Cai | M | 70 | 4 jaar | |
| Jérôme Benathan | M | - | 11 jaar | |
| Christian Lown | M | 54 | 3 jaar | |
| Derek Roy Crane | M | 50 | 3 jaar | |
| Barbara Artmann | F | 63 | 4 jaar | |
| Olav Noack | M | 56 | 5 jaar | |
| Robert J. Chersi | M | 62 | 10 jaar | |
| John Cryan | M | 63 | 3 jaar | |
| Kevin O'Shea | M | 58 | 6 jaar | |
| Luzius Cameron | M | 68 | - | |
| Rolf A. Meyer | M | 80 | 10 jaar | |
| Marco Suter | M | 65 | 34 jaar | |
| Stephan Haeringer | M | 77 | - | |
| Thomas Konrad Escher | M | 75 | - | |
| Marcel Ospel | M | 74 | 7 jaar | |
| Clive Standish | M | 71 | 5 jaar | |
| Alberto Togni | M | 84 | 7 jaar | |
| Jeffrey Diermeier | M | 71 | 4 jaar | |
| Leonard Patrick Gage | M | 81 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 3 jaar |
| Pierre E. Douaze | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 9 jaar |
| Larry Weinbach | M | 84 | 7 jaar | |
| Gabrielle Kaufmann-Kohler | F | 71 | - | |
| Thomas Lynch | M | 56 | 1 jaar | |
| David Sidwell | M | 71 | - | |
| Oswald J. Grübel | M | 80 | 2 jaar | |
| Ann Godbehere | F | 69 | - | |
| John Laurens Troost | M | 56 | 7 jaar | |
| Philip Atanasov Pashov | M | - | 4 jaar | |
| David Aufhauser | M | - | - | |
| Lorne Rupert Somerville | M | 60 | 7 jaar | |
| Melanie Gee | F | 63 | 9 jaar | |
| Andrea Buscaglia | M | 60 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 7 jaar |
| Andrew Look | M | 59 | 8 jaar | |
| King Leung Ngan | M | 40 | 6 jaar | |
| Michèle Ollier | M | 65 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 2 jaar |
| Alan Charles Hodson | M | 62 | - | |
| Jacques Theurillat | M | 65 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 19 jaar |
| Greg Bohlen | M | 65 | 2 jaar | |
| Jörg Wolfgang Wolle | M | 67 | 3 jaar | |
| Timothy Wells | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 9 jaar |
| Franck Latrille | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 13 jaar |
| Giampiero de Luca | M | 70 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 19 jaar |
| Leon Bushara | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 14 jaar |
| Bernard Mach | M | 90 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 10 jaar |
| Streiff Tom | M | - | 6 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Zwitserland | 96 | 96.00% |
| Verenigd Koninkrijk | 4 | 4.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Ernesto Bertarelli
- Persoonlijk netwerk
